Molecular quality controls market by Infectious Diseases, DNA Sequencing and Independent, Instrument Specific. Molecular quality controls market is driven primarily by rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, & rising demand for external quality assessment support. The infectious diseases segment accounted for the largest share of the molecular controls market in 2018.
Download Free PDF Brochure of Molecular Quality Controls Market Report Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1935584 .
Molecular quality controls market growing at 10.2% CAGR and expected to reach from USD 132 million in 2018 to USD 237 million by 2024. The growth of this market is primarily driven by factors such as the growing adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support.
“The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market.”
Market study covers molecular quality controls market across various segments. It aims at estimating market size & growth potential of this market across different segments byproduct, analyte type, application, end user, and region. Study also includes an in-depth competitive analysis of key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
- In 2018, Seracare partnered with AccuRef Diagnostics, a division of Applied StemCell, Inc (US), to market and sell Accuref’s broad portfolio of CRISPR-engineered cell line reference materials.
- In 2018, Thermo Fisher Scientific partnered with West China Hospital of Sichuan University (China) to establish training centers for standardized pathology quality control, standardized pathologic diagnosticians, and advanced laboratories.
- In 2017, Bio-Rad launched Amplichek STI—a Multi-analyte Quality Control
- In 2018, Microbiologics launched 8 quality control products such as, Human Papillomavirus (HPV) Control Panel, Vaginal Control Panel, Vaginal Verification Panel, Blood Culture (BCID) Control Panel, Enteric Viral Control Panel and others.
Ask for Discount on Molecular Quality Controls Market Research Report Now at http://www.rnrmarketresearch.com/contacts/discount?rname=1935584 .
Molecular controls market divided into four major segments—infectious diseases, oncology, genetic tests, and other applications. Infectious diseases segment accounted for largest share of molecular controls market in 2018. Large share of this segment is attributed to development of advanced assays for different infectious diseases, significant increase in prevalence of infectious diseases, & rising awareness about effective use of MDx technologies or products to control the occurrence & spread of infectious diseases.
Executives from various key organizations operating in the molecular quality controls market.
- By Company Type: Tier 1:40%, Tier 2: 30%, and Tier 3: 30%
- By Designation: C-level Executives: 27%, Directors: 18%, and Others:55%
- By Region: North America: 50%, Europe: 20%, APAC: 20%, and RoW: 10%
Key players in the molecular quality controls market include SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US). The study includes an in-depth competitive analysis of these key players in the molecular quality controls market, along with their company profiles, recent developments, and key market strategies.
Get Details on “Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) – Global Forecast to 2024” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1935584 .
Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.
North America accounted for the largest share of this market, followed by Europe. The large share of this regional segment is mainly due to the developed healthcare system in the US and Canada, the presence of a large number of leading molecular quality control product manufacturers, and easy accessibility to technologically advanced products in North America.